non prescription glp-1 Updates for Employers: Demand, Shortages, and Cost Comparing Ozempic, Wegovy and Other

Structure Therapeutics is among the most advanced challengers, with its oral GLP-1 receptor agonist aleniglipron generating Phase 2 data that has drawn significant industry attention

Diab Care 42 , 507513 (2019)

Thats incredibly effective for weight loss, but it creates a problem: when youre eating far less than you used to, your body needs energy from somewhere

The SEMALEAN trial found lean mass declined then stabilised while handgrip strength improved by 4.5 kg and sarcopenic obesity prevalence fell from 49% to 33% over twelve months

Patients interested in accessing it should speak with their GP or visit the NIHR 'Be Part of Research' portal

Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a provider's discretion and professional judgement